Clinical trials in Ravensburg – page 6

Extensive trials focusing on hormone receptor-positive and HER2-negative breast cancer treatments, evaluating innovative therapeutic combinations and targeted approaches.

• Early-stage breast cancer therapies
• Metastatic breast cancer treatments
• Endocrine therapy combinations

Studies examining novel drug combinations including ribociclib, abemaciclib, and innovative targeted therapies.

Groundbreaking research in chronic lymphocytic leukemia (CLL) and lymphomas, investigating new treatment protocols and drug combinations.

• CLL treatment strategies
• Follicular lymphoma therapies
• Targeted blood cancer treatments

Focus on venetoclax combinations and novel therapeutic approaches for elderly and frail patients.

Advanced research in ovarian cancer and endometrial cancer, exploring innovative treatment combinations and targeted therapies.

• Advanced ovarian cancer treatments
• Endometrial cancer therapies
• Combination treatment approaches

Studies evaluating niraparib, dostarlimab, and other targeted therapeutic options.